Affected user(s):
Primarily physicians and clinical staff involved in managing preventative care for patients on testosterone replacement therapy.
This request would benefit all providers who monitor patients receiving hormone therapy.
Task affected:
The issue arises during the preventative care workflow in MYLE, specifically under the Preventative Activity section.
There is currently no specific item for tracking PSA (Prostate-Specific Antigen) monitoring in the context of testosterone replacement therapy.
Impact:
The absence of this item makes it difficult to track and standardize appropriate PSA monitoring for patients on TRT.
Adding it as a dedicated preventative activity would improve consistency, documentation, and patient safety.
Frequency: Ongoing, as PSA monitoring is a routine part of care for this patient population.